Becton Dickinson (BDX) Total Current Liabilities (2009 - 2026)
Becton Dickinson (BDX) reported Total Current Liabilities of $8.5 billion for Q1 2026, up 10.61% year-over-year from $7.7 billion in Q1 2025, and down 2.9% quarter-over-quarter from $8.8 billion in Q4 2025.
Becton Dickinson (BDX) Total Current Liabilities (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has 18 years of Total Current Liabilities data on file, last reported at $8.5 billion in Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $8.5 billion, up 10.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.5 billion (up 10.61% YoY), and the FY2025 annual result was $8.3 billion, down 7.18% from the prior year.
- Total Current Liabilities fell to $8.5 billion in Q1 2026 per BDX's latest filing, from $8.8 billion in the prior quarter.
- Over five years, Total Current Liabilities peaked at $9.0 billion in Q3 2024 and troughed at $6.6 billion in Q2 2024.
- A 5-year average of $7.6 billion and a median of $7.6 billion in 2022 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2023 and 2024: Total Current Liabilities decreased 14.98% in 2023, then soared 34.86% in 2024.
- A 5-year view of Total Current Liabilities shows it stood at $7.6 billion in 2022, then slipped by 1.11% to $7.5 billion in 2023, then grew by 1.64% to $7.7 billion in 2024, then grew by 14.31% to $8.8 billion in 2025, then slipped by 2.9% to $8.5 billion in 2026.
- Business Quant data shows BDX's Total Current Liabilities at $8.5 billion in Q1 2026, $8.8 billion in Q4 2025, and $8.3 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 1.91 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 8.51 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 2.54 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 1.35 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 674.00 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 3.35 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 1.80 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.91 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 3.69 Bn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | 1.06 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.51 Bn |
| Dec 31, 2025 | 8.76 Bn |
| Sep 30, 2025 | 8.31 Bn |
| Jun 30, 2025 | 8.16 Bn |
| Mar 31, 2025 | 7.69 Bn |
| Dec 31, 2024 | 7.66 Bn |
| Sep 30, 2024 | 8.96 Bn |
| Jun 30, 2024 | 6.61 Bn |
| Mar 31, 2024 | 7.33 Bn |
| Dec 31, 2023 | 7.54 Bn |
| Sep 30, 2023 | 6.64 Bn |
| Jun 30, 2023 | 6.88 Bn |
| Mar 31, 2023 | 7.30 Bn |
| Dec 31, 2022 | 7.63 Bn |
| Sep 30, 2022 | 7.81 Bn |
| Jun 30, 2022 | 7.08 Bn |
| Mar 31, 2022 | 6.66 Bn |
| Dec 31, 2021 | 6.74 Bn |
| Sep 30, 2021 | 6.63 Bn |
| Jun 30, 2021 | 7.75 Bn |